U.S. National Institutes of Health
U.S. National Institutes of Health

IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2223122231Prospective Clinical Trial Evaluating Metronomic Chemotherapy in Patients With High-grade, Operable, Non-metastatic Osteosarcoma of the ExtremityRecruitingNo Results AvailableHigh Grade OsteosarcomaDrug: continuous oral cyclophosphamide and methotrexatehttps://ClinicalTrials.gov/show/NCT02273583
2223222232Optimal Anemia Treatment in End Stage Renal Disease (ERSD)RecruitingNo Results AvailableHyperparathyroidism, SecondaryDrug: standard care|Drug: Optimal (I. iPTH control: Zemplar®,Mimpara®; phosphorous control: Renvela®, Phoslo®, Osvaren®, Foznol®,Maalox®; calcium control: calcium and vitamin Dhttps://ClinicalTrials.gov/show/NCT02273570
2223322233Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: Asasantin ER (new formulation I - low)|Drug: Asasantin ER (new formulation III - medium)|Drug: Asasantin ER (new formulation II - high)|Drug: Asasantin ER (present commercial formulation)https://ClinicalTrials.gov/show/NCT02273557
2223422234Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male SubjectsTerminatedNo Results AvailableHealthyDrug: Asasantin ER (new formulation - low)|Drug: Asasantin ER (new formulation - medium)|Drug: Asasantin ER (new formulation - high)|Drug: Asasantin ER - commercial formulationhttps://ClinicalTrials.gov/show/NCT02273544
2223522235Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: Asasantin ER, new formulation|Drug: Asasantin ER, present commercial formulationhttps://ClinicalTrials.gov/show/NCT02273531
2223622236Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: Asasantin ER, new formulation I|Drug: Asasantin ER, new formulation II|Drug: Asasantin ER, present commercial formulationhttps://ClinicalTrials.gov/show/NCT02273518
2223722237Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy SubjectsCompletedNo Results AvailableHealthyDrug: Asasantin (ER)|Drug: Persantin|Drug: Acetyl salicylic acid (ASA)https://ClinicalTrials.gov/show/NCT02273505
2223822238Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy SubjectsCompletedNo Results AvailableHealthyDrug: Asasantin ER|Other: Standardized breakfasthttps://ClinicalTrials.gov/show/NCT02273492
2223922239Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Asasantin®|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02273479
2224022240Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: Desipramine tablet|Drug: Crobenetine infusion|Drug: Placebo infusionhttps://ClinicalTrials.gov/show/NCT02273466
2224122241Study to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night TabletsCompletedNo Results AvailableHealthyDrug: Songha® Night|Drug: Oxazepam|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02273453
2224222242Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BIIL 284 BS|Drug: Theophylline|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02273440
2224322243Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BIIL 284 BS|Other: high fat meal|Other: low fat mealhttps://ClinicalTrials.gov/show/NCT02273427
2224422244Study to Investigate the Safety, Tolerability, Biological Effects and Preliminary Pharmacokinetics of Increasing Doses of BIIL 284 BS in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BIIL 284 BS - rising dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02273414
2224522245Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 11054 CL Administered With the Respimat® in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 11054 CL|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02273401
2224622246BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid TumoursActive, not recruitingNo Results AvailableNeoplasmsDrug: BI 6727https://ClinicalTrials.gov/show/NCT02273388
2224722247Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLCRecruitingNo Results AvailableNon-Small Cell Lung CancerDrug: MEDI4736|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02273375
2224822248Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing SurgeryRecruitingNo Results AvailableAdult Liver CarcinomaDrug: Erlotinib Hydrochloride|Other: Laboratory Biomarker Analysis|Other: Quality-of-Life Assessmenthttps://ClinicalTrials.gov/show/NCT02273362
2224922249Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin DeficiencyRecruitingNo Results AvailableAlpha-1-Antitrypsin Deficiency|Chronic Obstructive Lung Disease|EmphysemaDevice: Lung Volume Reduction Coil (PneumrX Inc.)https://ClinicalTrials.gov/show/NCT02273349
2225022250Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung CancerRecruitingNo Results AvailableNon-small Cell Lung Cancer|Small Cell Lung CancerOther: cytology specimen collection procedure|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT02273336
2225122251Flow Mediated Dilation in Response to Black TeaRecruitingNo Results AvailableVascular FunctionOther: Tea|Other: Placebohttps://ClinicalTrials.gov/show/NCT02273323
2225222252Families Taking Control (FTC): Family-based Problem-solving Intervention for Children With Sickle Cell DiseaseCompletedNo Results AvailableSickle Cell DiseaseBehavioral: Problem Solving Training for Disease Managementhttps://ClinicalTrials.gov/show/NCT02273310
2225322253Healthy Start: Exploring the Fuel-mediated Programming of Neonatal GrowthActive, not recruitingNo Results AvailablePregnancy|ObesityOther: Maternal factorshttps://ClinicalTrials.gov/show/NCT02273297
2225422254Pain Perception of Children and Youth Receiving Non-sedated Botulinum Toxin-A Injections Using the Buzzy®RecruitingNo Results AvailablePainDevice: Buzzyhttps://ClinicalTrials.gov/show/NCT02273284
2225522255Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative ChemoNot yet recruitingNo Results AvailableNon-small Cell Lung CarcinomaOther: 18F-FLT-PET/CT and DWI-MRIhttps://ClinicalTrials.gov/show/NCT02273271
2225622256A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 DiabetesCompletedNo Results AvailableType 1 DiabetesDrug: SAR342434|Drug: Insulin Lispro|Drug: Insulin Lisprohttps://ClinicalTrials.gov/show/NCT02273258
2225722257Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome?Not yet recruitingNo Results AvailableAcute Aortic SyndromeRadiation: Thoracic aortogram CThttps://ClinicalTrials.gov/show/NCT02273245
2225822258Effects of Remote Ischemic Preconditioning on Moderate PVD Patients A Pilot Randomized Control TrialRecruitingNo Results AvailablePeripheral Arterial DiseasesOther: Remote Ischemic Preconditioning|Other: Supervised Exercise|Other: Standard Carehttps://ClinicalTrials.gov/show/NCT02273232
2225922259Trial of AEB071 in Combination With BYL719 in Patients With MelanomaRecruitingNo Results AvailableUveal MelanomaDrug: AEB071|Drug: BYL719https://ClinicalTrials.gov/show/NCT02273219
2226022260Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)RecruitingNo Results AvailableDepression|Breast Cancer Screening|Cervical Cancer Screening|Colorectal Cancer ScreeningBehavioral: Preventive Care Management for Depression|Behavioral: Preventive Care Management for Cancer Screeninghttps://ClinicalTrials.gov/show/NCT02273206

* Görseller ve İçerik tekif hakkına sahip olabilir